A Tailored Nurse Coaching Intervention for Oral Chemotherapy Adherence

Overview

Journal J Adv Pract Oncol

Date 2014 Aug 5

PMID 25089216

Citations 22

Authors

Susan M Schneider

Donna B Adams

Tracy Gosselin

Affiliations

Soon will be listed here.

Abstract

Although patients frequently express a preference for oral medications, compliance to these medications varies. Patients often have difficulty adhering to their medication schedules due to lack of understanding, inadequate support, or unwelcome side effects. Fostering adherence to oral chemotherapy regimens improves patients' chance of survival and long-term quality of life. This randomized trial tested the effectiveness of a tailored intervention to promote adherence to oral chemotherapeutic agents in 45 adult patients with cancer. The control group received the standard chemotherapy education provided at the cancer center. The intervention group received standard education and a tailored adherence plan developed by an advanced practice nurse. The nurse coaching intervention was administered via telephone. Adherence was measured using self-report and pharmacy refill rates. For adherence measures at both 2 and 4 months, the intervention group adherence rates were superior to the control group rates. Pharmacy refill rates of adherence were lower than self-reports. Results suggest that for some participants, the tailored coaching intervention was bene-ficial. Barriers to and facilitators of better adherence are discussed.

Citing Articles

Audio-Based Care for Managing Chronic Conditions in Adults: A Systematic Review.

Albritton J, Booth G, Kugley S, Reddy S, Coker-Schwimmer M, Fujita M Med Care. 2025; 63(2):164-182.

PMID: 39791849 PMC: 11708983. DOI: 10.1097/MLR.0000000000002097.

Feasibility pilot trial of a tailored medication adherence-promotion intervention for adolescents and young adults with cancer: Study design and protocol.

McGrady M, Ketterl T, Webster R, Schwartz L, Brock M, Szulczewski L Contemp Clin Trials. 2024; 139:107483.

PMID: 38431133 PMC: 10960689. DOI: 10.1016/j.cct.2024.107483.

Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.

Gil-Guillen V, Balsa A, Bernardez B, Valdes Y Llorca C, Marquez-Contreras E, de la Haba-Rodriguez J Int J Environ Res Public Health. 2022; 19(19).

PMID: 36231341 PMC: 9564665. DOI: 10.3390/ijerph191912036.

Timely Genetic Testing and Therapy Management in Patients With g-Mutated Metastatic Breast Cancer Receiving Talazoparib.

Martinez A, Jones T, Ryan J, Barnett C, Soussou E, Donahue S J Adv Pract Oncol. 2022; 13(7):705-712.

PMID: 36199494 PMC: 9514123. DOI: 10.6004/jadpro.2022.13.7.6.

Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer.

Shinn E, Busch B, Jasemi N, Lyman C, Toole J, Richman S Front Psychol. 2022; 13:856813.

PMID: 35903747 PMC: 9315289. DOI: 10.3389/fpsyg.2022.856813.

References

Reynolds N . The problem of antiretroviral adherence: a self-regulatory model for intervention. AIDS Care. 2003; 15(1):117-24. DOI: 10.1080/0954012021000039815. View

Schneider S, Hess K, Gosselin T . Interventions to promote adherence with oral agents. Semin Oncol Nurs. 2011; 27(2):133-41. PMC: 3653175. DOI: 10.1016/j.soncn.2011.02.005. View

Moore S . Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs. 2007; 30(2):112-22. DOI: 10.1097/01.NCC.0000265009.33053.2d. View

Portenoy R, Thaler H, Kornblith A, Lepore J, Kiyasu E, Sobel K . The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A(9):1326-36. DOI: 10.1016/0959-8049(94)90182-1. View

Liu G, Franssen E, Fitch M, Warner E . Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol. 1997; 15(1):110-5. DOI: 10.1200/JCO.1997.15.1.110. View

DAntonio L, Long S, Zimmerman G, Peterman A, PETTI G, Chonkich G . Relationship between quality of life and depression in patients with head and neck cancer. Laryngoscope. 1998; 108(6):806-11. DOI: 10.1097/00005537-199806000-00006. View

Twelves C, Gollins S, Grieve R, Samuel L . A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. Ann Oncol. 2005; 17(2):239-45. DOI: 10.1093/annonc/mdj023. View

Dodd M, Miaskowski C, Paul S . Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001; 28(3):465-70. View

Balkrishnan R . The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005; 43(6):517-20. DOI: 10.1097/01.mlr.0000166617.68751.5f. View

10.

Foley E, DAmico F, Merenstein J . Five-year follow-up of a nurse-initiated intervention to improve mammography recommendation. J Am Board Fam Pract. 1995; 8(6):452-6. View

11.

Escalada P, Griffiths P . Do people with cancer comply with oral chemotherapy treatments?. Br J Community Nurs. 2006; 11(12):532-6. DOI: 10.12968/bjcn.2006.11.12.22424. View

12.

Berwick D . What 'patient-centered' should mean: confessions of an extremist. Health Aff (Millwood). 2009; 28(4):w555-65. DOI: 10.1377/hlthaff.28.4.w555. View

13.

Ruddy K, Mayer E, Partridge A . Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59(1):56-66. DOI: 10.3322/caac.20004. View

14.

McCauley K, Bixby M, Naylor M . Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure. Dis Manag. 2006; 9(5):302-10. DOI: 10.1089/dis.2006.9.302. View

15.

Given B, Spoelstra S, Grant M . The challenges of oral agents as antineoplastic treatments. Semin Oncol Nurs. 2011; 27(2):93-103. DOI: 10.1016/j.soncn.2011.02.003. View